SANGAMO THERAPEUTICS, INC - 8-K Filing
Sangamo Therapeutics completed the sale of its Lilly Assets to Eli Lilly and Company for $50 million in cash. (Items: 1.03 Bankruptcy or Receivership, 2.01 below is incorporated into this Item 1, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $SGMO